Norton Rose Canada LLP
Norton Rose Canada is a member of Norton Rose Group, a leading international legal practice offering a full business law service to many of the world’s pre-eminent financial institutions and corporations from offices in Europe, Asia, Australia, Canada, Africa, the Middle East, Latin America and Central Asia.
Norton Rose Canada has more than 700 lawyers and patent and trade-mark agents practising in the areas of business, litigation, intellectual property, and employment and labour from offices in Calgary, Montréal, Ottawa, Toronto, Québec, Caracas and Bogotá. The practice was formed through the merger of Macleod Dixon and Norton Rose OR (formerly Ogilvy Renault) on January 1, 2012.
We are excited to be a tenant at MaRS. From our prime ground-floor space near the main entrance, we are thrilled to help MaRS’ emerging technology and life sciences with their legal needs at every stage of their growth.
We offer advice and insight on intellectual property and business planning to emerging life sciences and technology companies at MaRS. Our lawyers and agents are committed to assisting MaRS in its mandate to facilitate commercialization of great discoveries by Canadian researchers.
Our extensive experience in life sciences, technology and intellectual property has been achieved through working with some of the most innovative and ground-breaking companies in the world, including leading pharmaceutical and technology companies.
Our global pharmaceuticals and life sciences team consists of over 100 professionals, many of whom possess advanced scientific degrees and is consistently recognized as a leader in the life sciences area. In Canada, our team is comprised of over 65 life sciences experts with extensive corporate, commercial, regulatory and intellectual property expertise. Our team members have in-depth knowledge of the industry sectors they serve and a clear understanding of the business goals of companies at every stage of their growth. We can meet all of a company’s legal needs through every step of a product’s life cycle. We also anticipate and analyze emerging issues to assist life sciences companies in meeting the challenges of critical change.
Our technology team regularly advises both developers and users of technology in both the private and public sectors on a wide array of matters to structure, draft, negotiate and implement numerous information technology agreements and provides related transactional advice on corporate law, intellectual property law and other related matters. We act for a wide range of clients from small entrepreneurial start-ups through to and including large international private and public companies and government.
Our team of over 70 intellectual property professionals is one of the largest and highly regarded in Canada and has a long tradition of innovation and excellence in this field. We rely on extensive and varied technical expertise, coupled with a business-minded approach to helping our clients, whether start-up or multinational. We provide advice at the front end of the business cycle, helping to identify and evaluate inventions and marketing approaches in order to determine an appropriate filing, patent or trade-mark strategy. We also provide advice on how to get maximum value for IP assets, including audits and due diligence prior to and as a part of financing and corporate transactions and help companies enforce the protection of their IP.
Norton Rose Group has more than 2,900 lawyers in 43 offices worldwide. The practice is strong in financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and pharmaceuticals and life sciences. The practice comprises Norton Rose LLP, Norton Rose Australia, Norton Rose Canada LLP, Norton Rose South Africa (incorporated as Deneys Reitz Inc), and their respective affiliates.
Learn more at nortonrose.com.
